当前位置: 首页 >> 检索结果
共有 62504 条符合本次的查询结果, 用时 4.5318368 秒

1941. Pharmacist's Role in the Success of Blood Pressure Control Interventions: Evidence Isn't the Barrier….

作者: Ross T Tsuyuki.;Florian Rader.
来源: Circ Cardiovasc Qual Outcomes. 2024年17卷8期e011175页

1942. Role of Health Care Professionals in the Success of Blood Pressure Control Interventions in Patients With Hypertension: A Meta-Analysis.

作者: Katherine T Mills.;Samantha S O'Connell.;Meng Pan.;Katherine M Obst.;Hua He.;Jiang He.
来源: Circ Cardiovasc Qual Outcomes. 2024年17卷8期e010396页
Globally, only 13.8% of patients with hypertension have their blood pressure (BP) controlled. Trials testing interventions to overcome barriers to BP control have produced mixed results. Type of health care professional delivering the intervention may play an important role in intervention success. The goal of this meta-analysis is to determine which health care professionals are most effective at delivering BP reduction interventions.

1943. Transgender and Nonbinary Individuals' Perceptions Regarding Gender-Affirming Hormone Therapy and Cardiovascular Health: A Qualitative Study.

作者: Chantal L Rytz.;Badal S B Pattar.;Sara J Mizen.;Parker Lieb.;Jeanna Parsons Leigh.;Nathalie Saad.;Sandra M Dumanski.;Lauren B Beach.;Zack Marshall.;Amelia M Newbert.;Lindsay Peace.;Sofia B Ahmed.
来源: Circ Cardiovasc Qual Outcomes. 2024年17卷9期e011024页
Transgender and nonbinary individuals face substantial cardiovascular health uncertainties. The use of gender-affirming hormone therapy can be used to achieve one's gender-affirming goals. As self-rated health is an important predictor of health outcomes, an understanding of how this association is perceived by transgender and nonbinary individuals using gender-affirming hormone therapy is required. The objective of this research was to explore transgender and nonbinary individuals' perceptions of cardiovascular health in the context of using gender-affirming hormone therapy.

1944. Estimating the Impact of Hospital-Level Variation on the Use of Inpatient Rehabilitation Facilities Versus Skilled Nursing Facilities on Individual Patients With Stroke.

作者: Kent P Simmonds.;James Burke.;Alan Kozlowski.;Michael Andary.;Zhehui Luo.;Mathew J Reeves.
来源: Circ Cardiovasc Qual Outcomes. 2024年17卷9期e010636页
There is substantial hospital-level variation in the use of Inpatient Rehabilitation Facilities (IRFs) versus Skilled Nursing Facilities (SNFs) among patients with stroke, which is poorly understood. Our objective was to quantify the net effect of the admitting hospital on the probability of receiving IRF or SNF care for individual patients with stroke.

1945. Prioritizing Patient Perspectives: Cardiovascular Health of Transgender and Nonbinary People.

作者: Carl G Streed.;Asa E Radix.
来源: Circ Cardiovasc Qual Outcomes. 2024年17卷9期e011319页

1946. Heart Failure Events After Long-term Continuous Screening for Atrial Fibrillation: Results From the Randomized LOOP Study.

作者: Lucas Yixi Xing.;Søren Højberg.;Derk W Kriegerg.;Claus Graff.;Morten S Olesen.;Jeff S Healey.;William F McIntyre.;Axel Brandes.;Lars Køber.;Ketil Jørgen Haugan.;Jesper Hastrup Svendsen.;Søren Zöga Diederichsen.
来源: Circ Arrhythm Electrophysiol. 2024年17卷8期e012764页
Mounting evidence indicates that even device-detected subclinical atrial fibrillation is associated with a higher risk of heart failure (HF). However, the potential impact of atrial fibrillation screening on HF remains unknown.

1947. Left Atrial Myopathy in Heart Failure With Preserved Ejection: Don't Raise the Roof!

作者: Ravi B Patel.;Sanjiv J Shah.
来源: Circ Cardiovasc Imaging. 2024年17卷7期e017137页

1948. Age- and Sex-Specific Myocardial Blood Flow Values in Patients Without Coronary Atherosclerosis on Rb-82 PET Myocardial Perfusion Imaging.

作者: Brett W Sperry.;Mark P Metzinger.;Ali O Ibrahim.;Randall C Thompson.;Yoon J Cho.;Phillip G Jones.;A Iain McGhie.;Timothy M Bateman.
来源: Circ Cardiovasc Imaging. 2024年17卷7期e016577页
Quantitative myocardial blood flow (MBF) on positron-emission tomography myocardial perfusion imaging is a measure of the overall health of the coronary circulation. The ability to adequately augment blood flow, measured by myocardial blood flow reserve (MBFR), is associated with lower major adverse cardiovascular events and all-cause mortality. The age-specific ranges of MBFR in patients without demonstrable coronary artery disease have not been well established. We aimed to determine the effect of age and sex on MBF in a cohort of patients without demonstrable coronary artery disease.

1949. Myocardial Blood Flow in Patients Without Coronary Artery Disease: Slowing Down With Age.

作者: Tiffany Dong.;Paul C Cremer.
来源: Circ Cardiovasc Imaging. 2024年17卷7期e017138页

1950. Predictors of Rapid Coronary Plaque Progression Measured by CT: More Opportunities to Optimize Prevention.

作者: Bruna R Scarpa Matuck.;Armin Arbab-Zadeh.
来源: Circ Cardiovasc Imaging. 2024年17卷7期e017135页

1951. Elevated Lipoprotein(a) With Zero Coronary Artery Calcium: A Silent Threat or a Clinical Paradox?

作者: Patricia F Rodriguez Lozano.;Nisha Hosadurg.
来源: Circ Cardiovasc Imaging. 2024年17卷7期e017136页

1952. Rapid Plaque Progression Is Independently Associated With Hyperglycemia and Low HDL Cholesterol in Patients With Stable Coronary Artery Disease: A PARADIGM Study.

作者: Danilo Neglia.;Chiara Caselli.;Erica Maffei.;Filippo Cademartiri.;Antonella Meloni.;Eduardo Bossone.;Luca Saba.;Sang-Eun Lee.;Ji Min Sung.;Daniele Andreini.;Mouaz H Al-Mallah.;Matthew J Budoff.;Kavitha Chinnaiyan.;Jung Hyun Choi.;Eun Ju Chun.;Edoardo Conte.;Ilan Gottlieb.;Martin Hadamitzky.;Yong Jin Kim.;Byoung Kwon Lee.;Jonathon A Leipsic.;Hugo Marques.;Pedro de Araújo Gonçalves.;Gianluca Pontone.;Sanghoon Shin.;Peter H Stone.;Habib Samady.;Renu Virmani.;Jagat Narula.;Leslee J Shaw.;Jeroen J Bax.;Fay Y Lin.;James K Min.;Hyuk-Jae Chang.
来源: Circ Cardiovasc Imaging. 2024年17卷7期e016481页
We assessed whether combinations of cardiometabolic risk factors independently predict coronary plaque progression (PP) and major adverse cardiovascular events in patients with stable coronary artery disease.

1953. Lipoprotein(a) and Coronary Plaque in Asymptomatic Individuals: The Miami Heart Study at Baptist Health South Florida.

作者: Reed Mszar.;Miguel Cainzos-Achirica.;Javier Valero-Elizondo.;Shubham Lahan.;Sadeer G Al-Kindi.;Renato Quispe.;Shozab S Ali.;Lara Arias.;Anshul Saxena.;Svati H Shah.;Ricardo C Cury.;Matthew J Budoff.;Michael J Blaha.;Michael D Shapiro.;Garima Sharma.;Raul D Santos.;Ron Blankstein.;Theodore Feldman.;Jonathan Fialkow.;Khurram Nasir.
来源: Circ Cardiovasc Imaging. 2024年17卷7期e016152页
Elevated levels of lipoprotein(a) (Lp(a)) are independently associated with an increased risk of atherosclerotic cardiovascular disease events. However, the mechanisms driving this association are poorly understood. We aimed to evaluate the association between Lp(a) and coronary plaque characteristics in a contemporary US cohort without clinical atherosclerotic cardiovascular disease, undergoing coronary computed tomography angiography, the noninvasive gold standard for the assessment of coronary atherosclerosis.

1954. How to Use Cardiac Magnetic Resonance Imaging in Myocardial Infarction With Nonobstructive Coronary Arteries.

作者: Per Tornvall.;John F Beltrame.;Jannike Nickander.;Peder Sörensson.;Harmony R Reynolds.;Stefan Agewall.
来源: Circ Cardiovasc Imaging. 2024年17卷7期e016463页
The working diagnosis Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA) is being increasingly recognized with the common use of high-sensitivity troponins and coronary angiography, accounting for 5% to 10% of all acute myocardial infarction presentations. Cardiac magnetic resonance (CMR) imaging is pivotal in patients presenting with suspected MINOCA, mainly to delineate those with a nonischemic cause, for example, myocarditis and Takotsubo syndrome, from those with true ischemic myocardial infarction, that is, MINOCA. The optimal timing for CMR imaging in patients with suspected MINOCA has been uncertain and, until recently, not been examined prospectively. Previous retrospective studies have indicated that the diagnostic yield decreases with time from the acute event. The SMINC studies (Stockholm Myocardial Infarction with Normal Coronaries) show that CMR should be performed early in all patients with the working diagnosis of MINOCA, with the possible exception of patients who are clearly identified as having Takotsubo syndrome as determined by echocardiography. In addition to CMR imaging, other investigations of importance in selected patients may be pulmonary artery computed tomography to exclude pulmonary embolism, optical coherence tomography to identify plaque disruption, and acetylcholine provocation to identify coronary artery spasm. Imaging of patients with the working diagnosis MINOCA, which is centered on CMR together with supplemental investigations, results in a clear diagnosis in approximately three-quarters of the patients. This is a good example of personalized medicine, because a correct diagnosis will not only increase the satisfaction of the individual patient but also result in optimizing treatment without harming the patient.

1955. Comprehensive Assessment and Periprocedural Prognostic Significance of Aortic Tortuosity in Transfemoral Transcatheter Aortic Valve Implantation.

作者: Marc Bonnet.;Ludovic Maxo.;Lionel Mangin.;Pierre-Yves Courand.;Cécile Ricard.;Anissa Bouali.;Loïc Boussel.;Sébastien Gerelli.;Pierre Lantelme.;Brahim Harbaoui.
来源: Circ Cardiovasc Imaging. 2024年17卷7期e016814页

1956. Left Atrial Roof Enlargement Is a Distinct Feature of Heart Failure With Preserved Ejection Fraction.

作者: Sören J Backhaus.;Anastasia Nasopoulou.;Torben Lange.;Alexander Schulz.;Ruben Evertz.;Johannes T Kowallick.;Gerd Hasenfuß.;Pablo Lamata.;Andreas Schuster.
来源: Circ Cardiovasc Imaging. 2024年17卷7期e016424页
It remains unknown to what extent intrinsic atrial cardiomyopathy or left ventricular diastolic dysfunction drive atrial remodeling and functional failure in heart failure with preserved ejection fraction (HFpEF). Computational 3-dimensional (3D) models fitted to cardiovascular magnetic resonance allow state-of-the-art anatomic and functional assessment, and we hypothesized to identify a phenotype linked to HFpEF.

1957. Past, Present, and Future of Shared Decision-Making.

作者: Daniel D Matlock.;Larry R Jackson.;Amneet Sandhu.;Laura D Scherer.
来源: Circ Cardiovasc Qual Outcomes. 2024年17卷7期e010584页

1958. Recurring and Emerging Ethical Issues in Pragmatic Clinical Trials.

作者: Caleigh Propes.;P Pearl O'Rourke.;Stephanie R Morain.
来源: Circ Cardiovasc Qual Outcomes. 2024年17卷7期e010847页

1959. Distal Ventricular Pacing for Drug-Refractory Mid-Cavity Obstructive Hypertrophic Cardiomyopathy: A Randomized, Placebo-Controlled Trial of Personalized Pacing.

作者: James W Malcolmson.;Rebecca K Hughes.;Tim Husselbury.;Kamran Khan.;Annastazia E Learoyd.;Martin Lees.;Eleanor C Wicks.;Jamie Smith.;Alexander D Simms.;James C Moon.;Luis R Lopes.;Constantinos O'Mahony.;Neha Sekhri.;Perry M Elliott.;Steffen E Petersen.;Mehul B Dhinoja.;Saidi A Mohiddin.
来源: Circ Arrhythm Electrophysiol. 2024年17卷7期e012570页
Patients with refractory, symptomatic left ventricular (LV) mid-cavity obstructive (LVMCO) hypertrophic cardiomyopathy have few therapeutic options. Right ventricular pacing is associated with modest hemodynamic and symptomatic improvement, and LV pacing pilot data suggest therapeutic potential. We hypothesized that site-specific pacing would reduce LVMCO gradients and improve symptoms.

1960. Sirt1 Deficiency Promotes Age-Related AF Through Enhancing Atrial Necroptosis by Activation of RIPK1 Acetylation.

作者: Xuexin Jin.;Yun Zhang.;Yun Zhou.;Yingchun Luo.;Xuejie Han.;Yunlong Gao.;Hui Yu.;Yu Duan.;Ling Shi.;Yue Wu.;Yue Li.
来源: Circ Arrhythm Electrophysiol. 2024年17卷7期e012452页
Aging is one of the most potent risk determinants for the onset of atrial fibrillation (AF). Sirts (sirtuins) have been implicated in the pathogenesis of cardiovascular disease, and their expression declines with aging. However, whether Sirts involved in age-related AF and its underlying mechanisms remain unknown. The present study aims to explore the role of Sirts in age-related AF and delineate the underlying molecular mechanisms.
共有 62504 条符合本次的查询结果, 用时 4.5318368 秒